Naama Hammel, None;
Akram Belghith, None;
Felipe Medeiros, Alcon Laboratories Inc. (F), Alcon Laboratories Inc. (R), Allergan Inc. (C), Allergan Inc. (F), Allergan Inc. (R), Bausch & Lomb (F), Carl Zeiss Meditec Inc. (C), Carl Zeiss Meditec Inc. (F), Carl Zeiss Meditec Inc. (R), Heidelberg Engineering Inc. (F), Merck Inc. (F), National Eye Institute (F), Novartis (C), Reichert Inc. (F), Reichert Inc. (R), Sensimed (F), Topcon Inc. (F);
Nadia Mendoza, None;
yang qin, None;
Zhiyong Yang, None;
Robert Weinreb, Aerie (F), Alcon Laboratories (C), Allergan Inc. (C), Amatek (C), Aquesys (C), Bausch & Lomb (C), Carl Zeiss Meditec Inc. (C), Carl Zeiss Meditec Inc. (F), Genentech (F), Heidelberg Engineering GmbH (F), Nidek Inc. (F), Novartis (F), Optovue Inc. (F), Topcon Medical Systems Inc. (C), Topcon Medical Systems Inc. (F), Valeant (C);
Linda Zangwill, Carl Zeiss Meditec Inc. (F), Heidelberg Engineering GmbH (F), Nidek Inc. (F), Optovue Inc. (F), Quark (F), Topcon Medical Systems Inc. (F)